SUPT4H1 and Huntington disease: To investigate the potential therapeutic effects of SUPT4H1 knockdown in iPSC-NPCs, we first established NPC differentiation from iPSCs derived from an HD patient with 57 CAG repeats (Cell line ID: ND41656, RUCDR cell line service).